https://treelip.com/ 2026-07-11T05:13:58.109Z weekly 1 https://treelip.com/generic-entry-radar/ 2026-07-11T05:13:58.109Z weekly 0.9 https://treelip.com/generic-entry-radar/watchlist/ 2026-07-11T05:13:58.109Z weekly 0.85 https://treelip.com/generic-entry-radar/methodology/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/olux-e/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/alvesco/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/zetonna/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/erivedge/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/farydak/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/revlimid/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/finacea/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/sorilux/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/cresemba/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/zolinza/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/rytary/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/trokendi-xr/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/koselugo/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/zipsor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/verkazia/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/brisdelle/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/qsymia/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/atrovent-hfa/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/acuvue-theravision-with-ketotifen/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/verdeso/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/symbicort-aerosphere/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/apriso/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/namenda-xr/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/amitiza/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/emend/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/entereg/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/gilenya/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/oracea/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/zyclara/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/xelpros/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/xalkori/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/tivorbex/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/ninlaro/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/zorvolex/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/airsupra/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/mydayis/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/zokinvy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/chlorhexidine-gluconate/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/fabior/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/namzaric/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/embeda/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/ofev/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/vraylar/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/vonjo/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/juxtapid/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/olysio/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/ 2026-07-11T05:13:58.109Z weekly 0.9 https://treelip.com/translational-deal-radar/reports/cell-therapy-deal-radar/ 2026-07-11T05:13:58.109Z weekly 0.85 https://treelip.com/translational-deal-radar/methodology/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/autologous-tumor-infiltrating-lymphocytes/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/tumor-biopsy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/screening-platform/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/dual-target-car-nk-cells/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/autologous-hematopoietic-stem-cell-transplantation/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/selinexor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/eb-dtkn-401-allogeneic-dual-target-cspg4-gd2-car-nk-cells/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/anti-cd19-car-nk/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/sz003-car-nk/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/eb-dt-nk-uc101/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/anti-bcma-car-nk/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/eb-dt-car-nk/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/eb-dualnk/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/anti-cd22-car-nk-cells/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/eb-duo-car-nk-cea-gcc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/anti-mesothelin-car-nk-cells/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/act-001-car-nk-cell/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/allogenic-cd19-car-nk-cells/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/bicar-nk-cells-robo1-car-nk-cells/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/anti-cd33-car-nk-cells/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/translational-deal-radar/institution/inge-marie-svane/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/gustave-roussy-cancer-campus-grand-paris/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/glaxosmithkline/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/beijing-biotech/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/m-d-anderson-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/tianjin-medical-university-cancer-institute-and-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/second-affiliated-hospital-school-of-medicine-zhejiang-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/shantou-university-medical-college/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/shahid-beheshti-university-of-medical-sciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/allife-medical-science-and-technology-co-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/renji-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/xuzhou-medical-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/asclepius-technology-company-group-suzhou-co-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/persongen-biotherapeutics-suzhou-co-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/ 2026-07-11T05:13:58.109Z weekly 0.9 https://treelip.com/tools/adc-target-strategy-radar/oncology/ 2026-07-11T05:13:58.109Z weekly 0.85 https://treelip.com/tools/adc-target-strategy-radar/oncology/methodology/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/her2-erbb2/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/trop2-tacstd2/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/nectin-4-nectin4/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/b7-h3-cd276/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/cldn18-2-claudin-18-2/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/fra-folr1-folate-receptor-alpha/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/egfr/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/c-met-met/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/ror1/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/gpc3/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/psma-folh1/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/cd30-tnfrsf8/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/cd33/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/cd79b/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/bcma-tnfrsf17/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/muc1/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/napi2b-slc34a2/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/dll3/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/liv-1-slc39a6/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/ptk7/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/abbvie/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/abgenomics-b-v-taiwan-branch/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/academic-and-community-cancer-research-united/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/adc-therapeutics-s-a/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/adrienne-g-waks/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/akeso/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/alteogen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/ambrx/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/ana-c-garrido-castro-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/astrazeneca/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/beijing-gobroad-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/bicycletx-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/bio-thera-solutions/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/bioatla/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/biohaven-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/biontech-se/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/biying-chen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/bolt-biotherapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/bristol-myers-squibb/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/british-columbia-cancer-agency/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/byondis-b-v/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/cancer-institute-and-hospital-chinese-academy-of-medical-sciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/celldex-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/centre-hospitalier-universitaire-de-saint-etienne/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/charite-university-berlin-germany/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/chia-tai-tianqing-pharmaceutical-group-nanjing-shunxin-pharmaceutical/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/china-medical-university-china/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/chinese-university-of-hong-kong/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/chong-kun-dang-pharmaceutical/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/city-of-hope-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/conjupro-biotherapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/corbus-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/cspc-megalith-biopharmaceutical/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/cspc-zhongqi-pharmaceutical-technology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/cstone-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/cullinan-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/daiichi-sankyo/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/daiichi-sankyo-taiwan-a-daiichi-sankyo/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/dana-farber-cancer-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/day-one-biopharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/deepa-jagadeesh/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/dongguan-people-s-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/dualitybio/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/eisai/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/eisbach-bio-gmbh/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/elevation-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/eli-lilly-and/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/emory-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/european-institute-of-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/evopoint-biosciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/exelixis/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/fondazione-del-piemonte-per-l-oncologia/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/fred-hutchinson-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/fudan-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/gbg-forschungs-gmbh/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/genentech/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/genequantum-healthcare-suzhou/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/generate-biomedicines/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/genmab/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/george-w-sledge-jr/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/gilead-sciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/glaxosmithkline/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/groupe-oncologie-radiotherapie-tete-et-cou/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/grupo-espanol-de-tumores-neuroendocrinos/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/gustave-roussy-cancer-campus-grand-paris/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/hansoh-biomedical-r-d/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/hebei-medical-university-fourth-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/henan-cancer-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/hoffmann-la-roche/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/iksuda-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/immunogen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/immunome/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/innolake-biopharm/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/institut-curie/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/institut-f-r-klinische-krebsforschung-ikf-gmbh-at-krankenhaus-nordwest/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/intergroupe-francophone-de-cancerologie-thoracique/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/istituto-clinico-humanitas/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/janssen-research-development/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/jenny-c-chang-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/jiangsu-alphamab-biopharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/jiangsu-hengrui-medicine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/jiyan-liu/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/jonsson-comprehensive-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/jules-bordet-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/kivu-bioscience/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/kristina-a-fanucci/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/latin-american-cooperative-oncology-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/laura-huppert-md-ba/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/lei-liu/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/liaoning-cancer-hospital-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/ligachem-biosciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/mabwell-shanghai-bioscience/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/macrogenics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/mayo-clinic/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/mbrace-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/medsir/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/memorial-sloan-kettering-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/merck-sharp-dohme/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/mersana-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/millennium-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/mirati-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/multitude-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/mythic-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/nader-sanai/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/national-cancer-center-japan/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/national-cancer-institute-nci/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/nbe-therapeutics-ag/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/neok-bio/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/northwestern-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/novelty-nobility/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/nrg-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/obi-pharma/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/open-innovation-partners/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/peking-union-medical-college/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/peking-union-medical-college-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/peking-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/peking-university-cancer-hospital-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/phrontline-biopharma/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/progenics-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/qilu-hospital-of-shandong-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/qilu-pharmaceutical/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/quantumleap-healthcare-collaborative/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/radboud-university-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/rayzebio/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/regeneron-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/remegen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/renji-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/reshma-l-mahtani-d-o/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/salubris-biotherapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/samsung-bioepis/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/samsung-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/sarah-sammons-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/scri-development-innovations/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/seagen-a-wholly-owned-subsidiary-of-pfizer/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/second-affiliated-hospital-of-soochow-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/second-affiliated-hospital-school-of-medicine-zhejiang-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/second-xiangya-hospital-of-central-south-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shandong-new-time-pharmaceutical/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shandong-provincial-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-fosun-pharmaceutical-industrial-development/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-fudan-zhangjiang-bio-pharmaceutical/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-gynecologic-oncology-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-hansoh-biomedical/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-henlius-biotech/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-junshi-bioscience/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-miracogen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-ninth-people-s-hospital-affiliated-to-shanghai-jiao-tong-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-zhongshan-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shayna-sarosiek-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/sheng-zhang/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shengjing-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/sichuan-kelun-biotech-biopharmaceutical/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/sichuan-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/solti-breast-cancer-research-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/sorrento-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/sotio-biotech-a-s/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/st-jude-children-s-research-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/sun-yat-sen-memorial-hospital-of-sun-yat-sen-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/sun-yat-sen-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/sutro-biopharma/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/swog-cancer-research-network/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/tang-du-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/the-first-affiliated-hospital-of-soochow-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/the-first-affiliated-hospital-of-zhengzhou-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/the-first-affiliated-hospital-with-nanjing-medical-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/the-methodist-hospital-research-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/the-netherlands-cancer-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/tianjin-conjustar-biologics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/tianjin-medical-university-cancer-institute-and-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/tubulis-gmbh/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/unc-lineberger-comprehensive-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/unicancer/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/university-health-network-toronto/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/university-hospital-caen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/university-medical-center-groningen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/university-of-alabama-at-birmingham/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/university-of-birmingham/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/university-of-california-san-francisco/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/university-of-southampton/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/velavigo-bio/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/wake-forest-university-health-sciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/washington-university-school-of-medicine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/west-china-second-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/west-german-study-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/whitehawk-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/xijing-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/xuanzhu-biopharmaceutical/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/yale-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/yan-xue/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/yonsei-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/zai-lab-shanghai/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/zhejiang-cancer-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/zymeworks-bc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/protocol-benchmark-radar/ 2026-07-11T05:13:58.109Z weekly 0.9 https://treelip.com/tools/protocol-benchmark-radar/lupus-nephritis/ 2026-07-11T05:13:58.109Z weekly 0.85 https://treelip.com/tools/protocol-benchmark-radar/lupus-nephritis/trials/ 2026-07-11T05:13:58.109Z weekly 0.8 https://treelip.com/tools/protocol-benchmark-radar/lupus-nephritis/methodology/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/ 2026-07-11T05:13:58.109Z weekly 0.9 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/ 2026-07-11T05:13:58.109Z weekly 0.85 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/methodology/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/alk-fusion/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/braf-v600e/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/brca1-2-mutation/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/cldn18-2-expression/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/egfr-exon-19-deletion/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/egfr-l858r/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/egfr-mutation/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/fgfr2-fusion/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/fr-alpha-folr1-expression/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/her2-erbb2-amplification/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/her2-erbb2-expression/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/hrd/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/idh1-mutation/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/kras-g12c/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/kras-g12d/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/met-exon-14-skipping/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/msi-h-dmmr/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/ntrk-fusion/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/pd-l1-expression/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/ret-fusion/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/ros1-fusion/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/tmb-high/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-breast-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-nsclc-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-nsclc-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-nsclc-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-nsclc-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-nsclc-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-nsclc-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-nsclc-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-melanoma-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-melanoma-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-breast-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-breast-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-gastric-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-gastric-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-breast-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-breast-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-breast-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-ovarian-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-ovarian-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-melanoma-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-melanoma-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-gastric-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-breast-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-ovarian-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-ovarian-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-ovarian-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-breast-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-breast-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-breast-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-colorectal-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-colorectal-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-colorectal-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-colorectal-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-colorectal-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-colorectal-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-colorectal-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-pancreatic-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-colorectal-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-colorectal-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-colorectal-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-colorectal-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-nsclc-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-colorectal-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-colorectal-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-colorectal-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-colorectal-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-colorectal-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-melanoma-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-melanoma-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-melanoma-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-melanoma-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-melanoma-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-melanoma-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-melanoma-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-melanoma-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-melanoma-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-melanoma-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-melanoma-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-melanoma-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-nsclc-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-nsclc-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-nsclc-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-nsclc-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-nsclc-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-nsclc-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-nsclc-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-nsclc-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-nsclc-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-melanoma-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-melanoma-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-pancreatic-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-pancreatic-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-nsclc-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-nsclc-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-nsclc-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-nsclc-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-nsclc-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-nsclc-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-nsclc-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-nsclc-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-nsclc-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-nsclc-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-melanoma-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-melanoma-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-gastric-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-gastric-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-breast-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-breast-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-breast-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-breast-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-breast-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-breast-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-pancreatic-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-pancreatic-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-gastric-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-colorectal-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-colorectal-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-colorectal-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-colorectal-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-breast-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-gastric-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-gastric-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-gastric-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-gastric-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-gastric-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-ovarian-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-nsclc-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-nsclc-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-nsclc-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-ovarian-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/idh1-mut-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-breast-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-breast-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-ovarian-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-colorectal-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-colorectal-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-colorectal-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-nsclc-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-solid-tumor-basket-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-breast-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-breast-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-breast-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-breast-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-breast-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-melanoma-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-melanoma-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-melanoma-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-gastric-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-gastric-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-breast-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-melanoma-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-melanoma-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-colorectal-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-colorectal-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-colorectal-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-colorectal-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-colorectal-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-breast-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-pancreatic-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-pancreatic-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-breast-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-melanoma-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-melanoma-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-melanoma-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-breast-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fgfr2-fusion-breast-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-melanoma-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-melanoma-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-breast-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-ovarian-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-melanoma-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-melanoma-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-melanoma-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-breast-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-colorectal-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-colorectal-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-breast-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-breast-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-breast-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-breast-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-ovarian-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-ovarian-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-ovarian-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-gastric-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-gastric-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-gastric-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-gastric-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-gastric-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-gastric-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-gastric-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-gastric-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-ovarian-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-ovarian-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-ovarian-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-ovarian-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-ovarian-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-breast-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-ovarian-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-ovarian-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-ovarian-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-melanoma-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-nsclc-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-nsclc-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-gastric-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-gastric-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-gastric-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-melanoma-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-breast-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-pancreatic-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-pancreatic-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-pancreatic-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-colorectal-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-colorectal-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-ovarian-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fgfr2-fusion-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/idh1-mut-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-pancreatic-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-pancreatic-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-pancreatic-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-pancreatic-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-pancreatic-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-pancreatic-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-gastric-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-gastric-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-gastric-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-gastric-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-ovarian-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-gastric-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-pancreatic-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-nsclc-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/idh1-mut-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-pancreatic-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-pancreatic-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-pancreatic-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-nsclc-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-nsclc-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-nsclc-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-ovarian-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-nsclc-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-nsclc-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-nsclc-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-colorectal-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-colorectal-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-colorectal-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-colorectal-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-solid-tumor-basket-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-solid-tumor-basket-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-solid-tumor-basket-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-breast-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fgfr2-fusion-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-colorectal-cancer-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-colorectal-cancer-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-colorectal-cancer-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-colorectal-cancer-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-colorectal-cancer-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-colorectal-cancer-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-colorectal-cancer-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-pancreatic-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-pancreatic-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-pancreatic-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-breast-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-breast-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-breast-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fgfr2-fusion-breast-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-nsclc-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-nsclc-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-nsclc-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-melanoma-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-melanoma-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-melanoma-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-nsclc-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-breast-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-breast-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-solid-tumor-basket-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-gastric-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-nsclc-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-nsclc-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-nsclc-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-nsclc-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-gastric-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-colorectal-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-gastric-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-gastric-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-gastric-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-gastric-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-ovarian-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-ovarian-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-ovarian-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-ovarian-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-gastric-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-gastric-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fgfr2-fusion-gastric-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-gastric-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-gastric-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fgfr2-fusion-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-nsclc-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-nsclc-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-nsclc-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-nsclc-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-nsclc-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-nsclc-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-nsclc-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-nsclc-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-nsclc-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-gastric-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-gastric-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-gastric-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-gastric-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-gastric-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-nsclc-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-ovarian-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-pancreatic-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-pancreatic-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-pancreatic-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-solid-tumor-basket-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-breast-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-breast-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-breast-cancer-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-breast-cancer-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-breast-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-gastric-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-melanoma-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-melanoma-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-gastric-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-colorectal-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-ovarian-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-gastric-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fgfr2-fusion-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-ovarian-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fgfr2-fusion-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/idh1-mut-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-pancreatic-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-ovarian-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-gastric-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-nsclc-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-pancreatic-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-pancreatic-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-pancreatic-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-pancreatic-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-pancreatic-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-pancreatic-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-pancreatic-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-melanoma-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-melanoma-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-melanoma-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-colorectal-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-ovarian-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-melanoma-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-breast-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-gastric-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-gastric-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-breast-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-pancreatic-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-pancreatic-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-pancreatic-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-pancreatic-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-gastric-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-gastric-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-gastric-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-nsclc-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-breast-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-colorectal-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-breast-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-breast-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-nsclc-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-ovarian-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-ovarian-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-ovarian-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-ovarian-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-ovarian-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-ovarian-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-nsclc-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/idh1-mut-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-melanoma-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-ovarian-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-breast-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-solid-tumor-basket-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-pancreatic-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-pancreatic-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-colorectal-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-gastric-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-nsclc-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-solid-tumor-basket-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-pancreatic-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fgfr2-fusion-gastric-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/idh1-mut-gastric-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-pancreatic-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-nsclc-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-ovarian-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-solid-tumor-basket-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-ovarian-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-nsclc-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-ovarian-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-breast-cancer-therapy-not-normalized/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-ovarian-cancer-small-molecule-inhibitor/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-ovarian-cancer-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-ovarian-cancer-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-ovarian-cancer-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-ovarian-cancer-adc/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-breast-cancer-monoclonal-antibody/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-breast-cancer-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-solid-tumor-basket-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-nsclc-combination-therapy/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/23andme,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/3d-medicines-(sichuan)-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/4d-pharma-plc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/7-hills-pharma,-llc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/a2-biotherapeutics-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/abbisko-therapeutics-co,-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/abbvie/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/abramson-cancer-center-at-penn-medicine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ac-camargo-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/academic-and-community-cancer-research-united/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/academic-thoracic-oncology-medical-investigators-consortium/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/academisch-medisch-centrum---universiteit-van-amsterdam-(amc-uva)/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/acceleron-pharma,-inc.,-a-wholly-owned-subsidiary-of-merck-&-co.,-inc.,-rahway,-nj-usa/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/accent-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/adagene-(suzhou)-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/adagene-inc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/adc-therapeutics-s.a./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/adherex-technologies,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/advaxis,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ago-research-gmbh/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ahs-cancer-control-alberta/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aids-malignancy-consortium/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aio-studien-ggmbh/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aiping-zhou/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ajou-university-school-of-medicine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/akeso/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aktion-bronchialkarzinom-e.v./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/albert-einstein-college-of-medicine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/alessandro-santin/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/alethia-biotherapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/alexander-b-olawaiye,-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/all-india-institute-of-medical-sciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/allarity-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/allegheny-singer-research-institute-(also-known-as-allegheny-health-network-research-institute)/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/alliance-for-clinical-trials-in-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/alliance-foundation-trials,-llc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/allist-pharmaceuticals,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/alpha-biopharma-(jiangsu)-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/alphamab-(australia)-co-pty-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/american-society-of-clinical-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/amgen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aminex-therapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/amsterdam-umc,-location-vumc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ana-c-garrido-castro,-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/anbogen-therapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/andrew-b-lassman,-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/anhui-provincial-cancer-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/anova-innovation-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/anwaar-saeed/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/apexigen-america,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/apollomics-(australia)-pty.-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/apollomics-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aptose-biosciences-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aravive,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/arcagy/-gineco-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/arcus-biosciences,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/arno-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/arqule,-inc.,-a-subsidiary-of-merck-sharp-&-dohme-llc,-a-subsidiary-of-merck-&-co.,-inc.-(rahway,-nj-usa)/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/array-biopharma/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/arrivent-biopharma,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/arvinas-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/asan-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/asbjørn-mohr-drewes/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/askgene-pharma,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aslan-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/assistance-publique---hôpitaux-de-paris/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/assistance-publique-hopitaux-de-marseille/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/assiut-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/astellas-pharma-global-development,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/astellas-pharma-inc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/astex-pharmaceuticals,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aston-sci.-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/astrazeneca/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/atreca,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/augusta-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/australasian-gastro-intestinal-trials-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aveo-pharmaceuticals,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/avistone-biotechnology-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/baodong-qin/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/barbara-ann-karmanos-cancer-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/barbara-parker,-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/base-therapeutics-(shanghai)-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/basilea-pharmaceutica/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/bayer/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/baylor-breast-care-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/baylor-college-of-medicine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/bebetter-med-inc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beigene/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beijing-302-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beijing-biotech/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beijing-innocare-pharma-tech-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beijing-mabworks-biotech-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beijing-pearl-biotechnology-limited-liability-company/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beijing-sanbo-brain-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beijing-shenogen-biomedical-co.,-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beone-medicines/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beta-pharma-shanghai/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beth-israel-deaconess-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/betta-pharmaceuticals-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/bicycletx-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/bio-thera-solutions/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/biocity-biopharmaceutics-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/biogenea-pharmaceuticals-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/biontech-se/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/biontech-us-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/biosplice-therapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/biotech-pharmaceutical-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/biotheus-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/blokhin's-russian-cancer-research-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/blossomhill-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/blueprint-medicines-corporation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/boehringer-ingelheim/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/bolt-biotherapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/borstkanker-onderzoek-groep/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/brenus-pharma/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/briacell-therapeutics-corporation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/bristol-myers-squibb/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/british-columbia-cancer-agency/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/buzzard-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/calico-life-sciences-llc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/calithera-biosciences,-inc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/calliditas-therapeutics-suisse-sa/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cambridge-university-hospitals-nhs-foundation-trust/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/camilla-qvortrup/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/can-fite-biopharma/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/canadian-cancer-trials-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cancer-hospital-chinese-academy-of-medical-science,-shenzhen-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cancer-institute-and-hospital,-chinese-academy-of-medical-sciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cancer-research-uk/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/canwell-biotech-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/capital-medical-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/carrick-therapeutics-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/carsgen-therapeutics-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/case-comprehensive-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/casi-pharmaceuticals,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/celest-therapeutics-(shanghai)-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/celgene/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cellcentric-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cellceutix-corporation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/celldex-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cellectar-biosciences,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centocor,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/central-european-society-for-anticancer-drug-research/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centre-francois-baclesse/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centre-georges-francois-leclerc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centre-hospitalier-universitaire-dijon/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centre-hospitalier-universitaire-vaudois/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centre-integre-universitaire-de-sante-et-services-sociaux-du-nord-de-l'ile-de-montreal/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centre-leon-berard/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centro-nacional-de-investigaciones-oncologicas-carlos-iii/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cg-oncology,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chang-gung-memorial-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/changchun-genescience-pharmaceutical-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/changhai-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chen-chunyan/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chen-xiaozhong/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chengdu-baiyu-pharmaceutical-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chia-tai-tianqing-pharmaceutical-group-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chia-tai-tianqing-pharmaceutical-group-nanjing-shunxin-pharmaceutical-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/children's-national-research-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/children's-oncology-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/china-medical-university,-china/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/china-medical-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chinese-academy-of-medical-sciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chinese-pla-general-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chipscreen-biosciences,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chongqing-precision-biotech-co.,-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chonnam-national-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chu-de-quebec-universite-laval/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chuangzhen-chen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chungbuk-national-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/city-clinical-oncology-hospital-no-1/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/city-of-hope-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/clifford-hospital,-guangzhou,-china/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/clinica-universidad-de-navarra,-universidad-de-navarra/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cliniques-universitaires-saint-luc--université-catholique-de-louvain/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/clovis-oncology,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/coherent-biopharma-(suzhou)-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/col-george-peoples,-md,-facs/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/collin-blakely/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/columbia-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/concordia-laboratories-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/conjupro-biotherapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/consorzio-oncotech/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/corbus-pharmaceuticals-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/craig-l-slingluff,-jr/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cspc-megalith-biopharmaceutical-co.,ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cspc-zhongqi-pharmaceutical-technology-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/curis,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/curon-biopharmaceutical-(australia)-co-pty-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/d3-bio-(wuxi)-co.,-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/daiichi-sankyo/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/daiichi-sankyo-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/dan-zandberg/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/dana-farber-cancer-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/daping-hospital-and-the-research-institute-of-surgery-of-the-third-military-medical-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/dartmouth-hitchcock-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/david-garcia-cinca/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/debiopharm-international-sa/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/deciphera-pharmaceuticals,-llc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/diwakar-davar/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/dizal-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/dompé-farmaceutici-s.p.a/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/dong-a-st-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/dragonfly-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/duke-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/dwight-owen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/eastern-cooperative-oncology-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/eastern-hepatobiliary-surgery-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ecog-acrin-cancer-research-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/effector-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/eikon-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/eisai-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/eisai-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/elevation-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/eli-avisar,-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/eli-lilly-and-company/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/elicio-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/elizabeth-dudnik/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ella-therapeutics-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ellipses-pharma/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/elpiscience-biopharma,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/elucida-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/emd-serono/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/emd-serono-research-&-development-institute,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/emory-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/endocyte/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/enhancedbio-usa-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/enterome/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/epiaxis-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/epsilogen-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/erasca,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/essen-biotech/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/etop-ibcsg-partners-foundation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/european-institute-of-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/evelo-biosciences,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/evopoint-biosciences-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/exelixis/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/exicure,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/eye-&-ent-hospital-of-fudan-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/federation-francophone-de-cancerologie-digestive/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/filipa-lynce,-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/first-affiliated-hospital-of-wenzhou-medical-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/first-affiliated-hospital-of-zhejiang-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/first-affiliated-hospital-xi'an-jiaotong-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/first-people's-hospital-of-hangzhou/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/flame-biosciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/floor-backes,-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fondazione-del-piemonte-per-l'oncologia/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fondazione-irccs-istituto-nazionale-dei-tumori,-milano/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fondazione-per-la-medicina-personalizzata/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fondazione-policlinico-universitario-agostino-gemelli-irccs/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fondazione-ricerca-traslazionale/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/foresight-therapeutics-(hefei)-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fox-chase-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fred-hutchinson-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/frontier-medicines-corporation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fuda-cancer-hospital,-guangzhou/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fudan-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fujian-cancer-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fujian-medical-university-union-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fundacio-clinic-barcelona/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fundacion-clinic-per-a-la-recerca-biomédica/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fundacion-oncosur/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fundación-gecp/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fundación-pública-andaluza-para-la-gestión-de-la-investigación-en-sevilla/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/galena-biopharma,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gangnam-severance-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gary-schwartz/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gbg-forschungs-gmbh/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gcs-ramsay-santé-pour-l'enseignement-et-la-recherche/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/genelux-corporation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/genentech,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/generos-biopharma-hangzhou-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/genmab/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/genome-&-company/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/genprex,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gercor---multidisciplinary-oncology-cooperative-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/german-cancer-research-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gesellschaft-fur-medizinische-innovation---hamatologie-und-onkologie-mbh/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gilead-sciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/glaxosmithkline/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/glycyx-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/goethe-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gog-foundation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/groupe-francais-de-pneumo-cancerologie/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/groupe-oncologie-radiotherapie-tete-et-cou/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/grupo-espanol-de-investigacion-en-sarcomas/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/grupo-espanol-de-tumores-neuroendocrinos/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/grupo-español-de-investigación-en-cáncer-de-ovario/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/grupo-español-de-tratamiento-de-tumores-de-cabeza-y-cuello/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gruppo-oncologico-del-nord-ovest/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gruppo-oncologico-italiano-di-ricerca-clinica/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/guang'anmen-hospital-of-china-academy-of-chinese-medical-sciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/guangdong-association-of-clinical-trials/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/guangdong-provincial-people's-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/guangzhou-medical-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/guangzhou-sinogen-pharmaceutical-co.,-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/guangzhou-university-of-traditional-chinese-medicine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/guangzhou-xiling-biotechnology-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/guoxin-li/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gustave-roussy,-cancer-campus,-grand-paris/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/guy's-and-st-thomas'-nhs-foundation-trust/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gy-highland-biotech-llc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gynecologic-oncology-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/h.-lee-moffitt-cancer-center-and-research-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hadassah-medical-organization/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/haider-mahdi/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/haihe-biopharma-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/haisco-pharmaceutical-group-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hallym-university-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/halozyme-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hamilton-health-sciences-corporation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hangzhou-acea-pharmaceutical-research-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hangzhou-converd-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hangzhou-sumgen-biotech-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hangzhou-zhongmei-huadong-pharmaceutical-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hanmi-pharmaceutical-company-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/harbin-medical-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/harpoon-therapeutics,-inc.,-a-subsidiary-of-merck-&-co.,-inc.-(rahway,-new-jersey-usa)/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/haukeland-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hebei-medical-university-fourth-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/heidelberg-pharma-ag/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hellenic-cooperative-oncology-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hellenic-oncology-research-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/helsinki-university-central-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/helsinn-healthcare-sa/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/henan-cancer-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/henlix,-inc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/herbert-hurwitz,-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/highfield-biopharmaceuticals-corporation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hoffmann-la-roche/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hongmei-zheng,-phd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/honorhealth-research-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hospices-civils-de-lyon/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hospital-moinhos-de-vento/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/howard-safran/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/huabo-biopharm-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/huazhong-university-of-science-and-technology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hui-bu/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hunan-cancer-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hunan-province-tumor-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hutchison-medipharma-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hutchmed/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/huyabio-international,-llc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hyundai-bioscience-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hôpital-franco-britannique-fondation-cognacq-jay/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/i-mab-biopharma-us-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/iambic-therapeutics,-inc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ibrahim-halil-sahin/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/icahn-school-of-medicine-at-mount-sinai/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ideaya-biosciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ifom-ets---the-airc-institute-of-molecular-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ileukon-therapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/immix-biopharma-australia-pty-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/immune-system-key-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/immuneering-corporation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/immuneonco-biopharmaceuticals-(shanghai)-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/immunitybio,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/immunogen,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/immunovaccine-technologies,-inc.-(imv-inc.)/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/imperial-college-london/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/imugene-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/incepta-pharmaceuticals-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/incyte-biosciences-international-sàrl/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/incyte-corporation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/indaptus-therapeutics,-inc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/inhibrx-biosciences,-inc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/innolake-biopharm/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/innovent-biologics-(suzhou)-co.-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/inspirna,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/instil-bio/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-bergonié/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-cancerologie-de-l'ouest/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-claudius-regaud/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-curie/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-de-recherches-internationales-servier/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-du-cancer-de-montpellier---val-d'aurelle/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-fuer-frauengesundheit/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-für-klinische-krebsforschung-ikf-gmbh-at-krankenhaus-nordwest/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-mutualiste-montsouris/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-national-de-la-santé-et-de-la-recherche-médicale,-france/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-paoli-calmettes/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institute-of-cancer-research,-united-kingdom/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/instituto-do-cancer-do-estado-de-são-paulo/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/instituto-nacional-de-cancerologia-de-mexico/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/instituto-oncológico-dr-rosell/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/intensity-therapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/intergroupe-francophone-de-cancerologie-thoracique/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/inventisbio-co.,-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/inxmed-(shanghai)-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/irccs-azienda-ospedaliera-universitaria-san-martino---ist-istituto-nazionale-per-la-ricerca-sul-cancro,-genoa,-italy/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ismail-gögenur/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/istanbul-training-and-research-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/istituti-ospitalieri-di-cremona/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/istituto-romagnolo-per-lo-studio-dei-tumori-dino-amadori-irst-s.r.l.-irccs/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/italian-sarcoma-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jacobio-pharmaceuticals-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/janssen-research-&-development,-llc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jemincare/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jennifer-dorth/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jeremy-rudnick,-m.d/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jessica-mezzanotte-sharpe/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jian-chen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiangmen-central-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiangsu-alphamab-biopharmaceuticals-co.,-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiangsu-cancer-institute-&-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiangsu-hansoh-pharmaceutical-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiangsu-hengrui-medicine-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiangsu-province-nanjing-brain-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiangsu-simcere-pharmaceutical-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiangsu-yahong-meditech-co.,-ltd-aka-asieris/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jianming-xu/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiayuan-sun/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiesi-yingda-pharmaceutical-technology-(suzhou)-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jin-hyoung-kang/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jinming-yu/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiuda-zhao/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/johannes-gutenberg-university-mainz/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/john-l.-villano,-md,-phd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/john-strickler,-m.d./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/john-waters/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jonsson-comprehensive-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jules-bordet-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jun-huang/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jun-liu/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/k-group,-beta,-inc.,-a-wholly-owned-subsidiary-of-zentalis-pharmaceuticals,-inc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kadmon-corporation,-llc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kami-maddocks,-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/karolinska-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/karus-therapeutics-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kazia-therapeutics-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/keymed-biosciences-co.ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/klus-pharma-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/korea-university-anam-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kristen-ganjoo/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kumquat-biosciences-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kunming-medical-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kura-oncology,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kyntra-bio/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kyoto-breast-cancer-research-network/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kyowa-kirin-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/l-&-l-bio-co.,-ltd.,-ningbo,-china/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/lanova-medicines-development-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/lanova-medicines-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/lanova-medicines-zhejiang-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/latin-american-cooperative-oncology-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/lawrence-fong/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/legend-biotech-usa-inc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/leiden-university-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/li-zhang,-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/liaoning-cancer-hospital-&-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/lidds-ab/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ligachem-biosciences,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/liuying/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/liza-villaruz,-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/lung-cancer-group-cologne/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/luye-pharma-group-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/lynkcell-europe/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/lyvgen-biopharma-holdings-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/m.d.-anderson-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/maastricht-radiation-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mabxience-research-s.l./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/macrogenics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/marengo-therapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mario-negri-institute-for-pharmacological-research/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mark-vincent/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/marker-therapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/masaryk-memorial-cancer-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/masonic-cancer-center,-university-of-minnesota/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/massachusetts-general-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/maxinovel-pty.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mayo-clinic/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/medical-university-of-graz/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/medical-university-of-vienna/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/medicenna-therapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/medilink-therapeutics-(suzhou)-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/medimmune-llc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/medivir/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/medsir/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/melanoma-and-skin-cancer-trials-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/melanoma-institute-australia/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/melinda-telli/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/memorial-sloan-kettering-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/merck-kgaa,-darmstadt,-germany/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/merck-sharp-&-dohme-llc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mereo-biopharma/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/merrimack-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/merus-b.v./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/metanoic-health-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/michael-j-cavnar,-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/millennium-pharmaceuticals,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/milton-s.-hershey-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mirati-therapeutics-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mirna-therapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mohammed-milhem/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/molecular-templates,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/moma-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/monta-biosciences-aps/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/monte-rosa-therapeutics,-inc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/montefiore-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/moon-(guangzhou)-biotechnology-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/morphotek/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/multitude-therapeutics-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/multivir,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/myung-ju-ahn/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nammi-therapeutics-inc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nanfang-hospital,-southern-medical-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nanjing-first-hospital,-nanjing-medical-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nanjing-sanhome-pharmaceutical,-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nanobiotix/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nantes-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nantpharma,-llc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nasser-hanna/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/natera,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-cancer-center,-japan/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-cancer-center-hospital-east/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-cancer-centre,-singapore/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-cancer-institute,-naples/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-cancer-institute,-slovakia/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-cancer-institute-(nci)/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-guard-health-affairs/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-institute-of-health-research-and-development,-ministry-of-health-republic-of-indonesia/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-institutes-of-health-clinical-center-(cc)/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-taiwan-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-university-hospital,-singapore/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nationwide-children's-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/navire-pharma-inc.,-a-bridgebio-company/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ncic-clinical-trials-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nec-oncoimmunity-as/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nektar-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/neonc-technologies,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/neotx-therapeutics-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/neovii-biotech/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/new-beta-innovation-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nextcure,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nhs-greater-glasgow-and-clyde/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/niels-junker/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/niigata-university-medical-&-dental-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nikang-therapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nimbus-wadjet,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ningbo-junyan-hongshi-biosciences-co.,-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nisha-mohindra,-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nkmax-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/northwell-health/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/northwestern-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nouscom-srl/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/novartis-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/novelty-nobility,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nrg-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nucana-plc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nurix-therapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nuvation-bio-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nuvectis-pharma,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nyu-langone-health/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/obstetrics-&-gynecology-hospital-of-fudan-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/odense-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/odonate-therapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ohio-state-university-comprehensive-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ohsu-knight-cancer-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/olivia-newton-john-cancer-research-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/omico/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/on-target-laboratories,-llc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/oncoethix-gmbh,-a-subsidiary-of-merck-&-co.,-inc.-(rahway,-new-jersey-usa)/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/oncolytics-biotech/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/oncomed-pharmaceuticals,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/onconano-medicine,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/oncosec-medical-incorporated/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/oncxerna-theraputics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ono-pharmaceutical-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/oric-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/oryx-gmbh-&-co.-kg/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/oslo-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ospedale-policlinico-san-martino/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ottawa-hospital-research-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/p.o.-witteveen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/palleos-healthcare-gmbh/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/panolos-bioscience/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/parabilis-medicines,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/pediatric-brain-tumor-consortium/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/peking-union-medical-college/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/peking-union-medical-college-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/peking-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/peking-university-cancer-hospital-&-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/peking-university-first-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/peking-university-people's-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/peking-university-shenzhen-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/peking-university-third-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/people's-hospital-of-guangxi-zhuang-autonomous-region/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/pfizer/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/phanes-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/pharmamar/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/pharmicell-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/pharosgen-co.,ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/piramal-enterprises-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/pliant-therapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/precision-biotech-taiwan-corp./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/presage-biosciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/prescient-therapeutics,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/prisma-health-upstate/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/proacta,-incorporated/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/prof.-johann-bauer/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/puma-biotechnology,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/pure-biologics-s.a./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/pyramid-biosciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/qianfoshan-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/qiao-li/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/qilu-hospital-of-shandong-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/qilu-pharmaceutical-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/qiming-wang/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/qingdao-central-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/queen-mary-university-of-london/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/queensland-centre-for-gynaecological-cancer/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/qurebio-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/radboud-university-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/radiopharm-theranostics,-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/rain-oncology-inc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/rapa-therapeutics-llc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/redcloud-bio/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/regeneron-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/remegen-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/renji-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/renmin-hospital-of-wuhan-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/rennes-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/renske-altena/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/replimune,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/revolution-medicines,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/rigshospitalet,-denmark/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/rita-sanghvi,-mehta/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/robert-bok,-md,-phd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/roswell-park-cancer-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/royal-marsden-nhs-foundation-trust/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ruijin-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/rutgers,-the-state-university-of-new-jersey/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sameek-roychowdhury/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/samsung-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sanofi/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sarah-sammons,-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sarcoma-oncology-research-center,-llc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sciclone-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/scri-development-innovations,-llc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sds-optic-s.a./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/seagen,-a-wholly-owned-subsidiary-of-pfizer/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/seagen-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/second-affiliated-hospital,-school-of-medicine,-zhejiang-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/second-affiliated-hospital-of-nanchang-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/second-xiangya-hospital-of-central-south-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/seoul-national-university-bundang-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/seoul-national-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/seqker-biosciences,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/servier-bio-innovation-llc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shandong-cancer-hospital-and-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shandong-new-time-pharmaceutical-co.,-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shandong-provincial-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shandong-suncadia-medicine-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shandong-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-allink-biotherapeutics-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-best-link-bioscience,-llc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-cancer-hospital,-china/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-chest-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-chia-tai-tianqing-pharmaceutical-technology-development-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-children's-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-fosun-pharmaceutical-industrial-development-co.-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-general-hospital,-shanghai-jiao-tong-university-school-of-medicine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-hengrui-pharmaceutical-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-henlius-biotech/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-jiahui-international-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-jmt-bio-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-junshi-bioscience-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-kanda-biotechnology-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-longyao-biotechnology-inc.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-perhum-therapeutics-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-pulmonary-hospital,-shanghai,-china/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-qilu-pharmaceutical-research-and-development-center-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-university-of-traditional-chinese-medicine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-yingli-pharmaceutical-co.-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-zhongshan-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanxi-province-cancer-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shattuck-labs,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sheba-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shenzhen-fifth-people's-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shenzhen-people's-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shenzhen-university-general-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shijiazhuang-yiling-pharmaceutical-co.-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shionogi/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shouyao-holdings-(beijing)-co.-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sichuan-baili-pharmaceutical-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sichuan-cancer-hospital-and-research-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sichuan-huiyu-pharmaceutical-co.,-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sichuan-kelun-biotech-biopharmaceutical-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sichuan-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/signalchem-lifesciences-corporation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sihuan-pharmaceutical-holdings-group-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/silverback-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/simcha-il-18,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sir-run-run-shaw-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sixth-affiliated-hospital,-sun-yat-sen-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/smartnuclide-biopharma/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sofia-perea,-director-clinical-trials-unit./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/solti-breast-cancer-research-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sotio-biotech-a.s./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sotio-biotech-ag/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/spanish-breast-cancer-research-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/spanish-lung-cancer-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sparx-biotech(jiangsu)-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/st-vincent's-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/stanford-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/strata-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sue-yom/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sumitomo-pharma-america,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sun-yat-sen-memorial-hospital-of-sun-yat-sen-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sun-yat-sen-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sung-yong-lee/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sunshine-lake-pharma-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/susan-e.-bates/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/susanne-crocamo/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sutro-biopharma,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/suzhou-genhouse-bio-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/suzhou-immunofoco-biotechnology-co.,-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/suzhou-puhe-pharmaceutical-technology-co.,-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/suzhou-suncadia-biopharmaceuticals-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/suzhou-transcenta-therapeutics-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/suzhou-zelgen-biopharmaceuticals-co.,ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/swiss-cancer-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/swog-cancer-research-network/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/symphogen-a/s/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/syndax-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/synta-pharmaceuticals-corp./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tachyon-therapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/taiho-oncology,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/taipei-veterans-general-hospital,-taiwan/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/taizhou-eoc-pharma-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/taizhou-hanzhong-biomedical-co.-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/takeda/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tang-du-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tanta-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tata-memorial-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tcr2-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tehran-university-of-medical-sciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tel-aviv-sourasky-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/teligene-us/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tesaro,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tetralogic-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/thaddeus-pace/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-affiliated-hospital-of-qingdao-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-belgian-society-of-medical-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-first-affiliated-hospital-of-guangzhou-medical-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-first-affiliated-hospital-of-soochow-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-first-affiliated-hospital-of-xiamen-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-first-affiliated-hospital-of-zhengzhou-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-first-affiliated-hospital-with-nanjing-medical-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-first-hospital-of-jilin-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-fourth-affiliated-hospital-of-zhejiang-university-school-of-medicine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-hospital-for-sick-children/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-methodist-hospital-research-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-netherlands-cancer-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/therapex-co.,-ltd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/theras,-inc.,-d/b/a-bbot-(bridgebio-oncology-therapeutics)/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/third-affiliated-hospital,-sun-yat-sen-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/thomas-jefferson-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tian-xie/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tianjin-medical-university-cancer-institute-and-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tianjin-medical-university-second-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/timothy-burns,-md,-phd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tj-biopharma-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tolremo-therapeutics-ag/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tomsk-national-research-medical-center-of-the-russian-academy-of-sciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tongji-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tongji-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/topalliance-biosciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/trans-tasman-radiation-oncology-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/translational-genomics-research-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/translational-research-in-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/transthera-sciences-(nanjing),-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/triana-biomedicines,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/triumvira-immunologics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tty-biopharm/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/turning-point-therapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tyk-medicines,-inc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/udai-kammula/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/unc-lineberger-comprehensive-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/unicancer/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/union-hospital,-tongji-medical-college,-huazhong-university-of-science-and-technology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/universidad-europea-de-madrid/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/universitaire-ziekenhuizen-ku-leuven/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-college,-london/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-health-network,-toronto/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-hospital,-akershus/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-hospital,-bordeaux/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-hospital,-clermont-ferrand/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-hospital,-essen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-hospital,-toulouse/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-hospital-heidelberg/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-medical-center-groningen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-aarhus/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-alabama-at-birmingham/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-arizona/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-birmingham/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-california,-davis/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-california,-irvine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-california,-san-diego/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-california,-san-francisco/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-campania-luigi-vanvitelli/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-chicago/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-colorado,-denver/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-florida/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-iowa/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-kansas-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-l'aquila/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-lausanne-hospitals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-leicester/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-maryland,-baltimore/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-michigan-rogel-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-nebraska/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-oklahoma/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-pennsylvania/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-pittsburgh/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-sheffield/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-southampton/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-southern-california/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-texas-southwestern-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-turin,-italy/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-utah/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-virginia/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-washington/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-wisconsin,-madison/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-zurich/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/università-vita-salute-san-raffaele/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/us-department-of-veterans-affairs/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/us-oncology-research/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/va-office-of-research-and-development/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/vall-d'hebron-institute-of-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/vanderbilt-ingram-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/vejle-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/verastem,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/vincerx-pharma,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/vitrac-therapeutics,-llc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/vividion-therapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/vyriad,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/wake-forest-university-health-sciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/washington-university-school-of-medicine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/wayshine-biopharm,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/wei-xu/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/weill-medical-college-of-cornell-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/werewolf-therapeutics,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/west-china-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/west-china-second-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/west-virginia-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/william-bradley/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/wisp-wissenschaftlicher-service-pharma-gmbh/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/woman's/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/women's-hospital-school-of-medicine-zhejiang-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/worldwide-innovative-network-association/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/wuxi-no.-4-people's-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/xencor,-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/xijing-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/xinhua-hospital,-shanghai-jiao-tong-university-school-of-medicine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/xinqiao-hospital-of-chongqing/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/xu-jianmin/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/y-biologics-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/yale-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/yan-xue/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/yantai-yuhuangding-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/yongxu-jia/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/yonsei-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/yu-jiren/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/yuan-chen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/yugui-lian/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/yuhan-corporation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zai-biopharmaceutical-(suzhou)-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zai-lab-(shanghai)-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zealand-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhangzhou-municipal-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhejiang-cancer-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhejiang-doer-biologics-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhejiang-medicine-co.,-ltd./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhejiang-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhi-yang/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhiyong-yu/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhonglin-hao/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhongnan-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhujiang-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zuoyi-jiao/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zymeworks-bc-inc./ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/ 2026-07-11T05:13:58.109Z weekly 0.9 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/ 2026-07-11T05:13:58.109Z weekly 0.85 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/methodology/ 2026-07-11T05:13:58.109Z monthly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/1-mg-kg-iv-fl-301/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/177lu-psma-617/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/177lu-psma617/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/18f-fluciclovine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/3-dimensional-conformal-radiation-therapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/3d-conformal-external-beam/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/5-fluorouracil/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/68ga-dota-tate-pet-scan/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/68ga-psma/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/89zr-pembrolizumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/90y-y-pentixather/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/9mw2821/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/a-non-pcr-patients/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/a1-shr-a1811/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/a166/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/a6/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/abatacept-bms-188667/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/abemaciclib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/abiraterone-acetate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/abraxane/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/abt-263/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ac-adriamycin-a-also-known-as-doxorubicin-and-cyclophosphamide-c-followed-by-paclitaxel-p/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/adaptive-radiotherapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/adavosertib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/adc/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/adebrelimab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/adebrelimab-combined-with-bevacizumab-and-docetaxel/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/aflibercept/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ag-013736/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ak104/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ak105/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/akt-inhibitor-mk2206/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/albumin-bound-paclitaxel-plus-cisplatin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/alcestobart/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/aldesleukin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/alemtuzumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/allogeneic-t-cells/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/allogeneic-tumor-cell-vaccine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/allogeneic-tumour-lysate-melcancervac/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/allogenic-cd19-car-t-cell/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/american-ginseng-root/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/amg-706/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/amiodarone-hydrochloride/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/amt-116/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/amt-676/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/amxt-1501-dicaprate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anakinra-interleukin-1-receptor-antagonist/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anastrozole/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/androgen-deprivation-therapy-adt/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anetumab-ravtansine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anlotinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anlotinib-and-bempegaldesleukin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anlotinib-combined-docetaxel/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anlotinib-combined-with-dose-dense-temozolomide/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anlotinib-combined-with-sintilimab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anlotinib-hydrochloride/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anlotinib-hydrochloride-plus-docetaxel/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anti-b7h1-monoclonal-antibody-medi4736/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anti-ctla4-monoclonal-antibody-and-hdi/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anti-endoglin-chimeric-monoclonal-antibody-trc105/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anti-her2-adc/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anti-pd-1-monoclonal-antibody/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anti-steap1-car-t-cells/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anti-thymocyte-globulin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/antibody-drug-conjugate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/antibody-drug-conjugate-adc/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/apalutamide/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/apatinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/apatinib-monotherapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/apolizumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/arm-1-dc-vaccine-rt/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/arm1/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/arsenic-trioxide/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/art0380/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/artemicoffee/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/arx788/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ascorbic-acid/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/asp546c/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/atezobev-with-combined-radiotherapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/atezolizumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/atezolizumab-1200-mg-in-20-ml-injection/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/atezolizumab-injection-bevacizumab-injection/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-cd19-star-t-cell/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-dendritic-cell-tumor-fusion-vaccine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-dendritic-cell-vaccination/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-dendritic-cell-vaccine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-dendritic-cell-vaccine-dc-pc3/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-dendritic-cells/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-dendritic-cells-co-cultured-with-cytokine-induced-killer-cells/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-dendritic-cells-dc-vaccine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-dendritic-cells-electroporated-with-mrna/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-dendritic-cells-generated-using-gm-csf-interferon-alpha-and-lps/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-dendritic-cells-pulsed-with-tumor-lysate-antigen-vaccine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-hematopoietic-stem-cell-transplantation/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-tumor-cell-vaccine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/auy922/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/av-gbm-1/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/avastin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/avelumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/avova-1/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/avzo-103/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/axicabtagene-ciloleucel/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/azacitidine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/azd0516/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/azd0901/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/azd5363-when-combined-with-weekly-paclitaxel/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/azd6244/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/azd9291/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bat8006-for-injection/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bc-819-pei/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/becotatug-vedotin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/becotatug-vedotin-mrg003/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/belantamab-mafodotin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/belinostat-carboplatin-paclitaxel-and-bevacizumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bendamustine-hydrochloride/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/best-practice/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bev-gem-doc/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bevacizumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bevacizumab-and-etoposide/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bevacizumab-bev/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bexarotene/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bgj398-infigratinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bhb810/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bibf1120/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/biological-samples-collection/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/biological-single-dose-of-inaticabtagene-autoleucel/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/biopsy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/biopsy-before-and-after-three-weeks-of-study-treatment/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/biopsy-procedure/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/biospecimen-collection/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bkm120/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bl-m07d1/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bleomycin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bleomycin-sulfate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/blinatumomab-mt103/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bms-986183/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bnt324/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bnt326/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bnt329/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bortezomib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bpr-6023021-for-injection/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/brentuximab-vedotin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/busulfan/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bvd-523/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cab-axl-adc/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cab-ror2-adc/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cabazitaxel/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cabazitaxel-xrp6258/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cabozantinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cabozantinib-atezolizumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cadonilimab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/caelyx/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/camrelizumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/capecitabine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/capecitabine-and-aflibercept/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/capecitabine-cisplatin-sorafenib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/captopril/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/car-t-cells/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/carbo-cyclo/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/carboplatin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/carboplatin-auc-5-and-paclitaxel/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/carboplatin-bevacizumab-and-pemetrexed/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cardonilizumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/carfilzomib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cdgp-5-fu-combined-with-radiation/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cediranib-maleate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/celecoxib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/celecoxib-vinblastine-cyclophosphamide-methotrexate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cell-therapy-product/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cemiplimab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cetuximab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cetuximab-avelumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cetuximab-irdye800/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cetuximab-irinotecan-capecitabine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cevostamab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/chemotherapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/chemotherapy-plus-cemiplimab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/chidamide/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/chidamide-gemcitabine-cisplatin-immune-checkpoint-inhibitor/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/chlorine-dioxide-sterilization/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/chloroquine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ci-1033/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cisplatin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cixutumumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ckd-703/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/clarithromycin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/clofutriben/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cnto-328-anti-interleukin-6-monoclonal-antibody/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cobimetinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cohort-1-her2-positive-rc48-adc/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/com701-in-combination-with-bms-986207-and-nivolumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/combined-adenovirus-vectored-p53-tranfected-dedritic-cell-vaccine-and-ex-vivo-expanded-t-lymphocytes/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/computed-tomography/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/conventional-transarterial-chemoembolization-tace/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/crb-701/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/crizotinib-pf-02341066/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cromolyn-tqb2102-and-panpulimab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ct-and-mri-scans/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ctdna-test/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ctx-009/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ctx-009-abl001/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/curcumin-bcm-95/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cvac/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cx-2009/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cxcr1-2-inhibitor-sx-682/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cyberknife-sbrt/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cyclophosphamide/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cyclophosphamide-pemetrexed-5-fluorouracil/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cytarabine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dabrafenib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dacomitinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dalpiciclib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dalpiciclib-125mg/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dasatinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/datopotamab-deruxtecan/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/datopotamab-deruxtecan-dato-dxd/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/daunorubicin-hydrochloride/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/db-1311/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dc-vaccine-and-cyclophosphamide/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/decitabine-dtc-arm/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dendritic-cell-gp100-mart-1-antigen-vaccine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dendritic-cell-vaccine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dendritic-cells-vaccine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/denosumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/derazantinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/derazantinib-300-mg-once-daily-monotherapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dexamethasone/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dichloroacetate-dca/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/disitamab-vedotin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/disitamab-vedotin-anlotinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/disitamab-vedotin-injection/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/docetaxel/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/docetaxel-injection-oxaliplatin-s-1/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/docosahexaenoic-acid/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dostarlimab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dovitinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/doxorubicin-and-cisplatin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/doxorubicin-hydrochloride/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/doxycycline-50mg-tablet/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/drug-icp-192/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/drug-selumetinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/druid-ai-program/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ds-8201a/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ds3790a/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/duloxetine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/durvalumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/e7090/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/e7820/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/e7820-plus-cetuximab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/eb-701-ca9-nk/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/eb-dtnb-nk/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ebnk-001-il-15-pembrolizumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/edetate-calcium-disodium/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/egfrbi-armed-autologous-t-cells/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/eis-12656/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/electromagnetic-navigation-bronchoscopy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/emavusertib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/emb07/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/enapotamab-vedotin-humax-axl-adc/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/encorafenib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/enfortumab-vedotin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ensartinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/entinostat/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/entrectinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/env-501/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/envafolimab-combined-with-recombinant-human-endostatin-and-first-line-chemotherapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/envafolimab-injections-intravenous-disitamab-vedotin-carboplatin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/envofolimab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/enzalutamide/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/enzalutamide-dose-escalation/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/eras-007/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/eribulin-mesylate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/erlotinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/erlotinib-hydrochloride/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ertumaxomab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/es101/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/etanercept/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/etoposide/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/everolimus/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/everolimus-rad-001/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/evinacumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/exemestane/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/extended-dose-interval-immunotherapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/farletuzumab-ecteribulin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fg-3246/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/filgrastim/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/filgrastim-75mcg-0-3ml/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/flash-radiotherapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fludarabine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fludarabine-phosphate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fludarabine-phosphate-fludara/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fluorouracil/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fmiso/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/folfiri/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/folfiri-3/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/for46/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fractionated-dose-of-225ac-j591/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fulvestrant/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/futibatinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/g-202/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gamma-secretase-notch-signalling-pathway-inhibitor-ro4929097/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gc1008/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gdc-0810/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gefitinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gemcitabine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gemcitabine-etoposide/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gemcitabine-hydrochloride/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gemox/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gfh375/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/giredestrant/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/glofitamab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/glp-1-receptor-agonist/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gocatamig/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/goserelin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gq1001-pyrotinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/grt-c901/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gsk5764227/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gti-2040/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hb0025/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hbi-8000/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hdm201/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/herombopag-olamine-tablets/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hiltonol-and-autologous-dendritic-cells/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hlx43/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hlx43-dose-1/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hlx43-dose-1-2-0-mg-kg/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hlx43-dose-1-in-2l-tnbc/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hmpl-a251/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hpph/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hs-10296/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hs-20093/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/htert-mrna-dc/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/human-papillomavirus-9-valent-vaccine-recombinant/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hydroxychloroquine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hyperpolarized-13c-pyruvate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hyperpolarized-carbon-c-13-pyruvate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/i-dxd/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ibi129/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ibi343/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ibi351-combined-with-cetuximab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ibrutinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/idarubicin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ifinatamab-deruxtecan/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ifinatamab-deruxtecan-i-dxd/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/imatinib-mesylate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/imc-a12-cixutumumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/imexon/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/imgn632/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/imgn901/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/immu-130/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/immune-killer-cells-ikc/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/imvotamab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/inavolisib-in-combination-with-eribulin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/inc280/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/incb099280/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/indinavir-sulfate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/induction-phase/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/inotuzumab-ozogamicin-io/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/intensity-modulated-radiation-therapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/inv-8989/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/investigator-choice-re-challenge-with-anti-egfr-rx/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ip-001/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ip-paclitaxel/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ipilimumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/irinotecan/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/iron-chelation/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/irosustat/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/iruplinalkib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/isatuximab-sar650984/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/itraconazole-200-mg/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ivonescimab-combined-with-trop2-adc/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ixabepilone/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ixazomib-citrate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ixempra-ixabepilone-bms-247550/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/jk-1201i/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/jmt101/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/js207/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/js207-injection-docetaxel/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/kd018/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/khn922-for-injection/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/laboratory-biomarker-analysis/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ladiratuzumab-vedotin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lapatinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lapatinib-ditosylate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lbl-024-for-injection/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lcb02a/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lenalidomide/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lenalidomide-10-mg/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lenvatinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/letrozole/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lgx818/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/liplacis/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/liposomal-daunorubicin-citrate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/liposomal-doxorubicin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lirilumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lisocabtagene-maraleucel/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lm-302/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lm-302-candonilimab-capecitabine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/loncastuximab-tesirine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/low-dose-radiotherapy-to-the-intestine-ildr/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ly2157299/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/m9140/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mart-1-antigen/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mavrostobart-pt199/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/medi4736/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/medi4736-monotherapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/medi6469-monotherapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/megestrol-acetate-40-mg/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/melphalan-flufenamide-melflufen/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mesopher/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/metformin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/metformin-hydrochloride-500mg-tablet/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/methoxsalen/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mfolfirinox/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mhb036c-for-injection/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mhb048c-for-injection/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mhb088c-for-injection/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/microneedle-array-doxorubicin-mna-d/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mirvetuximab-soravtansine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mirvetuximab-soravtansine-gynx/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mirvetuximab-soravtansine-mirv-imgn853/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mk-1775/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mk-3120/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mk-3475/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mln4924/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mln9708/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/monalizumab-medi5257/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/morab-202/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mpdl3280a/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mrg002/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mrg003/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mrg003-and-toripalimab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mrg003-combined-with-dalpicicilip/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mrg006a/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mutant-p53-peptide-pulsed-dendritic-cell-vaccine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nab-paclitaxel/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nab-sirolimus/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/namodenoson-25mg/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nanoparticle-albumin-bound-paclitaxel/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nc410/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/neoadjuvant-chemotherapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/neoadjuvant-chemotherapy-nac/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/neratinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ngr-htnf/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nilutamide/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/niraparib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nivolumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nivolumab-240-mg-relatlimab-80-mg-in-a-fixed-dose-combination/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nivolumab-gx-188e-gx-i7/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nivolumab-ipilimumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nivolumab-plus-ipilimumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nkr-2/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/obinutuzumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/oblimersen-sodium/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/oh2/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/oh2-bs006/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/olaparib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/olvi-vec/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ompenaclid/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/opaganib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/osi-906/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/osimertinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/oxaliplatin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/oxaliplatin-5-fluorouracil/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/oxaliplatin-paclitaxel/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/oxaliplatin-with-gemcitabine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/paclitaxel/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/paclitaxel-and-cisplatin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/paclitaxel-carboplatin-bevacizumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/palbociclib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/palonosetron/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pamiparib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/panitumumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/panobinostat/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/part-1-vp-315-3-day-dosing-week/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pasireotide-som230/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/patritumab-deruxtecan/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/patupilone/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/paxalisib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pazopanib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pb-pb-advc001-phase-1b/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pd-0332991/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pd-l1-peptide/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pegfilgrastim-30mcg-kg/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pegylated-liposomal-doxorubicin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pembrolizumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pembrolizumab-eftilagimod-alfa/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pembrolizumab-injection-keytruda/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pembrolizumab-keytruda/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pembrolizumab-t3p-y058-739/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pemetrexed/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pemetrexed-phase-1/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pentamidine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/perifosine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/personalized-dendritic-cell-vaccine-zsneo-dc1-1/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pertuzumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pertuzumab-trastuzumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pexastimogene-devacirepvec-pexa-vec/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pf-03446962/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pf-04691502/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pf-3512676-erlotinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pf03446962/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pf804/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pharmacokinetic-study/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/phosphatidylcholine-curcumin-complex-supplement/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/photodynamic-therapy-pdt/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pik3ca-inhibitor/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/placebo/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/plinabulin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pm01183/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/polatuzumab-vedotin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pomalidomide/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pr610/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/prednisone/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/prophylactic-cranial-irradiation/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/propranolol/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/propranolol-hydrochloride/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/proton-therapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/psilocybin-25-mgs/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/psma-adc/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pt-112/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pucotenlimab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pyrotinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ql1706/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ql1706-bevacizumab-etoposide-cisplatin-or-carboplatin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ql1706-bispecific-antibody-targeting-pd-1-and-clta-4/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ql1706-cisplatin-paclitaxel-neoadjuvant-therapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/qlc5508/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/qlc5513/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/qlp2117/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/qls5132-bevacizumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/qls5133/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/quemliclustat/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/radiation-therapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/radiotherapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/radiotherapy-rituximab-and-dc/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/raltitrexed/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/raludotatug-deruxtecan/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ramosetron-aprepitant-dexamethasone/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ratt/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rc108/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rc118/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rc118-adc/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rc48-adc/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rc48-adc-2-5mg-kg/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rc48-adc-combined-with-toripalimab-for-bladder-sparing-therapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rc48-adc-toripalimab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rc48-combined-with-tislelizumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rc88/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rebimastat/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/recombinant-fowlpox-tricom-vaccine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/recombinant-human-il12-15-pdl1b-oncolytic-hsv-1-injection-vero-cell-in-combination-with-nivolumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/recombinant-human-interleukin-7/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/recombinant-humanized-anti-her2-monoclonal-antibody-mmae-coupling-agent-rc48-adc/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/recombinant-interferon-alfa/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/recombinant-interleukin-12/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/regorafenib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/regorafenib-40-mg/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/regorafenib-nivolumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/retifanlimab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ribociclib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ridaforolimus/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rifaximin-550-milligrams-mg/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rituximab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/romidepsin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rovalpituzumab-tesirine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rovalpituzumab-tesirine-sc16ld6-5/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ruxolitinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rvu120/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/s-1-plus-cisplatin-hipec/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/s-adenosyl-l-methionine-disulfate-p-toluene-sulfonate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sabarubicin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sac-tmt/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sacituzumab-govitecan/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sacituzumab-govitecan-hziy-sg/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sacituzumab-tirumotecan/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sacituzumab-tirumotecan-and-anlotinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sacituzumab-tirumotecan-and-limertinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sacituzumab-tirumotecan-combined-with-bevacizumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sacituzumab-tirumotecan-plus-tagitanlimab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sacituzumab-tirumotecan-skb264-plus-pembrolizumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/saracatinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sargramostim/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sbrt/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sbrt-with-protons-or-photons/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/screening-platform/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sd-101/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/selinexor/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/selinexor-60-mg/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/serplulimab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/serum-derived-bovine-immunoglobulin-protein-isolate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/setanaxib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sgi-110-dose-escalation/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sgi-110-guadecitabine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/shr-1210/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/shr-1681/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/shr-a1811/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/shr-a1811-adebrelimab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/shr-a1811-plus-ak112/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sintilimab-200mg-mb07133-600mg/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sitravatinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/skb103-for-injection-monotherapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/skb264/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sodium-pentaborate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sonidegib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sorafenib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sorafenib-tosylate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sotorasib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sox/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sp-002/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/spartalizumab-in-pediatric-cohort/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/spine-radiosurgery/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/srf388/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/stereotactic-body-radiotherapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sti-6129/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sulfasalazine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sulindac/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sunitinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sunitinib-malate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/surufatinib-envafolimab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/surufatinib-serplulimab-albumin-paclitaxel-gemcitabine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sutent/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sym015/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/synb1618/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sys6010-jnjection/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sys6010-sg001-physician-s-choice-capecitabine-or-5-fu/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sys6090-pemetrexed-platinum-based-chemotherapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/t-dm1/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tac-001/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tacrolimus-arm-with-methotrexate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tafasitamab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tak-188/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tak-700/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tak228/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/talazoparib-tosylate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tamoxifen-citrate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tarceva/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/taxotere/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tec/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/telaglenastat/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/temozolomide/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/temozolomide-100mg/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/temsirolimus-and-sorafenib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/testosterone-cypionate/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/th-302-monotherapy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/thalidomide/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/therapeutic-autologous-dendritic-cells/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/therapeutic-autologous-lymphocytes/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/thyroidectomy/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tiaoshen-anti-cancer-granules/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tipifarnib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tiragolumab-and-atezolizumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tirzepatide/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tislelizumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tislelizumab-bgb-a317/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tivozanib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tivozanib-hydrochloride/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tlk286/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tmz/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tobemstomig/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/topical-menthol/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/topical-tazarotene/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/toripalimab-injection-js001/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tovecimig/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tq-b3525/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tqb2102-for-injection/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tqb2450-injection/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tqb3454-tablets/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tqb3616-capsules/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tqb3728-tablets-tqb2450-injection-sequential-or-concurrent-chemoradiation/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tqb6411-injection/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/trametinib-0-5-mg/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/trans-resveratrol/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/trastuzumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/trastuzumab-cetuximab-irinotecan/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/trastuzumab-deruxtecan/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/trastuzumab-deruxtecan-t-dxd/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/trastuzumab-rezetecan/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/trastuzumab-rezetecan-for-injection-shr-a1811/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tst001/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tt-00420/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tub-030/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tub-040/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tucidinostat-chidamide-pd-1-inhibitor-tislelizumab-anlotinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tumor-antigen-loaded-autologous-dendritic-cells/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ultratrace-iobenguane-i131/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/unconjugated-belantamab-antibody/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/urelumab-nivolumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vascular-endothelial-growth-factor-receptor-vegfr-and-platelet-derived-growth-factor-receptor-pdgfr-inhibitor/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vb11/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vemurafenib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/venetoclax/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/venetoclax-decitabine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vibecototamab-iv-putilimab-iv/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vistusertib-azd2014/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vitamin-c/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vobramitamab-duocarmazine/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vobramitamab-duocarmazine-2-0-mg-arm-a/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/volrustomig/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/voreloxin-injection/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vs-6063/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/wbrt/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/wt-vdibh/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/wt1-prame-vaccination/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/wx-554/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/xnw27011/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/xofigo/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/y-90-sir-spheres/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/yf476/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/yh32364/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/yl202-should-be-intravenously-infused/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zanubrutinib-r2/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zanzalintinib/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zb716/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zenocutuzumab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zg006/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zg19018/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zilovertamab-vedotin/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ziv-aflibercept/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zo-nantax/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zolbetuximab/ 2026-07-11T05:13:58.109Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/aadi-bioscience/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/abbvie/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/abbvie-prior-sponsor-abbott/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/abramson-cancer-center-at-penn-medicine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/accuray-incorporated/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/actuate-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/adcendo-aps/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/advancell-pty-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ahmad-tarhini/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ain-shams-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/aivita-biomedical/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/akeso/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/allarity-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/alliance-for-clinical-trials-in-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/amgen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/amgen-research-munich-gmbh/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/aminex-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/amphera-bv/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/amplimed-corporation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/amsterdam-umc-location-vumc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/anchiano-therapeutics-israel/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/andres-j-m-ferreri/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/anqin-zhang/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/artios-pharma/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/asan-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/assistance-publique-h-pitaux-de-paris/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/assistance-publique-hopitaux-de-marseille/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/association-pour-la-recherche-des-th-rapeutiques-innovantes-en-canc-rologie/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/astellas-pharma/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/astellas-pharma-global-development/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/astrazeneca/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/australian-and-new-zealand-urogenital-and-prostate-cancer-trials-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/australian-new-zealand-children-s-haematology-oncology-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/auxilio-mutuo-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/avenzo-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/aveo-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/baptist-health-south-florida/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/barbara-ann-karmanos-cancer-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/basilea-pharmaceutica/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/baylor-research-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/beigene/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/beijing-biohealthcare-biotechnology-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/beijing-biotech/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/beijing-innocare-pharma-tech-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/beyondspring-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/bighat-biosciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/binhui-biopharmaceutical-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/bio-thera-solutions/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/bioatla/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/bioinvent-international-ab/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/biomed-valley-discoveries/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/biontech-se/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/blue-earth-diagnostics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/boehringer-ingelheim/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/bristol-myers-squibb/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/british-columbia-cancer-agency/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/calliditas-therapeutics-suisse-sa/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/cambridge-university-hospitals-nhs-foundation-trust/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/can-fite-biopharma/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/canadian-cancer-trials-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/case-comprehensive-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/celgene/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/celyad-oncology-sa/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/centocor/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/centre-antoine-lacassagne/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/centre-hospitalier-universitaire-de-saint-etienne/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/centre-leon-berard/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/centre-oscar-lambret/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chang-gung-memorial-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chao-family-comprehensive-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chengdu-kanghong-biotech-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chengdu-syncor-pharmaceutical-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chia-tai-tianqing-pharmaceutical-group-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chia-tai-tianqing-pharmaceutical-group-nanjing-shunxin-pharmaceutical-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/children-s-oncology-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/china-medical-university-china/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chinese-academy-of-medical-sciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chinese-pla-general-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chong-kun-dang-pharmaceutical/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chuangzhen-chen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/city-of-hope-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/clinica-universidad-de-navarra-universidad-de-navarra/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/coherus-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/columbia-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/compass-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/compugen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/consorzio-oncotech/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/corbus-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/corewell-health-west/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/cougar-biotechnology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/cspc-megalith-biopharmaceutical-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/curis/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/cytomx-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/daehwa-pharmaceutical-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/daiichi-sankyo/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/dana-farber-cancer-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/dongguan-people-s-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/drexel-university-college-of-medicine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/dualitybio/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/duke-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/eastern-cooperative-oncology-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/edward-chu-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/eisai/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/eisbach-bio-gmbh/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/eli-lilly-and-company/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/elpiscience-biopharma/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/emd-serono-research-development-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/emory-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/enhancedbio-usa/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/erasca/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/essen-biotech/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/european-institute-of-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/european-organisation-for-research-and-treatment-of-cancer-eortc/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/evopoint-biosciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/exelixis/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/falo-louis-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/far-eastern-memorial-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/federation-francophone-de-cancerologie-digestive/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/first-affiliated-hospital-of-zhejiang-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/flame-biosciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/fondazione-irccs-istituto-nazionale-dei-tumori-milano/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/fondazione-ricerca-traslazionale/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/fred-hutchinson-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/fudan-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/fujian-cancer-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/fujian-provincial-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/fundacion-cris-de-investigaci-n-para-vencer-el-c-ncer/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/genelux-corporation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/genentech/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/genfleet-therapeutics-shanghai/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/genmab/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/genspera/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/genzyme-a-sanofi-company/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/georgetown-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/gilead-sciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/glaxosmithkline/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/gog-foundation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/gritstone-bio/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/groupe-oncologie-radiotherapie-tete-et-cou/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/grupo-espa-ol-de-investigaci-n-en-c-ncer-de-ovario/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/grupo-espa-ol-de-tratamiento-de-tumores-de-cabeza-y-cuello/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/gruppo-italiano-malattie-ematologiche-dell-adulto/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/gruppo-italiano-per-lo-studio-dei-carcinomi-dell-apparato-digerente/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/gruppo-oncologico-del-nord-ovest/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/guangdong-association-of-clinical-trials/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/guangdong-provincial-people-s-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/guangzhou-university-of-traditional-chinese-medicine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/gynecologic-oncology-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/h-lee-moffitt-cancer-center-and-research-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hackensack-meridian-health/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hadassah-medical-organization/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/haider-mahdi/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hallym-university-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hamamatsu-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/handok/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hangzhou-jiuyuan-gene-engineering-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hansoh-biomedical-r-d-company/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/harbin-medical-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/heidelberg-pharma-ag/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/heinrich-elinzano-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/henan-cancer-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/herlev-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hoag-memorial-hospital-presbyterian/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hoffmann-la-roche/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/holy-cross-hospital-florida/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/honorhealth-research-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hope-rugo-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hu-hai/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/huabo-biopharm-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hummingbird-bioscience/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hutchmed/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/huyabio-international/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/igm-biosciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/immunitybio/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/immunogen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/imperial-college-london/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/incyte-corporation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/inge-marie-svane/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/innovent-biologics-suzhou-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/inspirna/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/institut-de-canc-rologie-de-lorraine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/institut-f-r-klinische-krebsforschung-ikf-gmbh-at-krankenhaus-nordwest/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/institute-of-cancer-research-united-kingdom/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/institute-of-hematology-blood-diseases-hospital-china/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/instituto-do-cancer-do-estado-de-s-o-paulo/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/instituto-oncol-gico-dr-rosell/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/intergroupe-francophone-de-cancerologie-thoracique/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/irccs-san-raffaele/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/istituto-romagnolo-per-lo-studio-dei-tumori-dino-amadori-irst-s-r-l-irccs/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ivy-life-sciences-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/jason-valent/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/jenkem-technology-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/jennifer-crombie-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/jiangsu-cancer-institute-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/jiangsu-hansoh-pharmaceutical-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/jiangsu-simcere-pharmaceutical-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/john-strickler-m-d/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/jonsson-comprehensive-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/jules-bordet-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/juno-therapeutics-a-subsidiary-of-celgene/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/kasr-el-aini-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/keshuzhou/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/klus-pharma/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/kura-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/kyntra-bio/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/lanova-medicines-zhejiang-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/laura-huppert-md-ba/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/lei-liu/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/lene-meldgaard-knudsen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/lepu-biopharma-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/liaoning-cancer-hospital-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ligachem-biosciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ludwig-maximilians-university-of-munich/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/lung-cancer-group-cologne/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/m-d-anderson-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/maastricht-radiation-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/mabwell-shanghai-bioscience-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/macrogenics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/marc-donath/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/maria-sklodowska-curie-national-research-institute-of-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/massachusetts-general-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/mayo-clinic/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/mbrace-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/medigene-ag/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/medilink-therapeutics-suzhou-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/medimmune/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/medsir/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/melanoma-institute-australia/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/melinda-telli/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/memorial-sloan-kettering-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/merck-sharp-dohme/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/merus-b-v/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/millennium-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/minghui-pharmaceutical-hangzhou/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/mirati-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/molecular-insight-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/montefiore-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/morphosys-ag/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/mount-vernon-cancer-centre-at-mount-vernon-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/mt-sinai-medical-center-miami/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/multitude-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/nanjing-leads-biolabs-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/nantes-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/national-cancer-center-japan/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/national-cancer-center-korea/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/national-cancer-institute-naples/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/national-cancer-institute-nci/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/national-guard-health-affairs/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/national-heart-lung-and-blood-institute-nhlbi/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/national-university-hospital-singapore/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ncic-clinical-trials-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/neovii-biotech/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/nextcure/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ngstrom-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/northside-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/northwestern-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/novartis-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/nrg-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/nsabp-foundation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/nyu-langone-health/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ohio-state-university-comprehensive-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ohsu-knight-cancer-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/oncopeptides-ab/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/oncozyme-pharma/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/oslo-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/peking-union-medical-college/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/peking-union-medical-college-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/peking-university-cancer-hospital-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/pentixapharm-ag/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/pfizer/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/phanes-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/pharmamar/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/prima-biomed/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/proacta-incorporated/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/providence-health-services/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/puma-biotechnology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/qed-therapeutics-a-bridgebio-company/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/qilu-hospital-of-shandong-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/qilu-pharmaceutical-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/radboud-university-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/radiation-therapy-oncology-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/rahul-aggarwal/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/redhill-biopharma-limited/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/regeneron-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/remegen-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/renji-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/revimmune/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/robert-bok-md-phd/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/rockefeller-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/roswell-park-cancer-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/royal-marsden-nhs-foundation-trust/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ruhr-university-of-bochum/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ruijin-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/russian-academy-of-medical-sciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ryvu-therapeutics-sa/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/saint-francis-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/samsung-medical-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sanofi/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sc-liver-research-consortium/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sciclone-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/scri-development-innovations/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/seagen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/second-affiliated-hospital-school-of-medicine-zhejiang-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/seoul-national-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shandong-cancer-hospital-and-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-changzheng-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-chest-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-epimab-biotherapeutics-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-henlius-biotech/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-jmt-bio/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-junshi-bioscience-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-miracogen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-municipal-hospital-of-traditional-chinese-medicine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-pulmonary-hospital-shanghai-china/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-zhongshan-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shayna-sarosiek-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shenzhen-ionova-life-sciences-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sichuan-baili-pharmaceutical-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sichuan-kelun-biotech-biopharmaceutical-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sichuan-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sir-run-run-shaw-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sorrento-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/southern-illinois-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sparrow-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/st-james-s-hospital-ireland/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/st-joseph-s-healthcare-hamilton/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/st-joseph-s-hospital-and-medical-center-phoenix/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/st-jude-children-s-research-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/stamford-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/stemcentrx/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/stichting-european-myeloma-network/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sun-yat-sen-memorial-hospital-of-sun-yat-sen-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sun-yat-sen-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sunesis-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sunnybrook-health-sciences-centre/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/susanne-crocamo/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/suzhou-suncadia-biopharmaceuticals-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/suzhou-zelgen-biopharmaceuticals-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/swiss-cancer-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/swog-cancer-research-network/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/symbio-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/symphogen-a-s/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/syndax-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/synlogic/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/t3-pharmaceuticals-ag/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/tabriz-university-of-medical-sciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/taiho-oncology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/takeda/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/tallac-therapeutics/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/tang-du-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/tata-memorial-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/telik/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/the-christie-nhs-foundation-trust/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/the-cleveland-clinic/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/the-first-affiliated-hospital-of-xinxiang-medical-college/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/the-first-affiliated-hospital-of-zhengzhou-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/the-first-affiliated-hospital-with-nanjing-medical-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/the-netherlands-cancer-institute/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/the-university-of-texas-health-science-center-houston/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/therakos/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/tianjin-medical-university-cancer-institute-and-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/tongji-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/transgene/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/transthera-sciences-nanjing/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/trio-medicines/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/trisalus-life-sciences/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/tubulis-gmbh/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/unc-lineberger-comprehensive-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/unicancer/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/union-hospital-tongji-medical-college-huazhong-university-of-science-and-technology/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/universit-vita-salute-san-raffaele/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-college-london/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-health-network-toronto/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-hospital-bordeaux/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-hospital-lille/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-medical-center-groningen/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-alabama-at-birmingham/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-alberta/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-arizona/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-california-davis/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-california-irvine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-california-san-francisco/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-chicago/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-colorado-denver/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-florida/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-miami/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-michigan-rogel-cancer-center/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-sao-paulo/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-southampton/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-southern-california/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-turin-italy/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-washington/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-wisconsin-madison/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/us-oncology-research/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/velosbio-a-subsidiary-of-merck-co-rahway-new-jersey-usa/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/verastem/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/verrica-pharmaceuticals/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/washington-university-school-of-medicine/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/weill-medical-college-of-cornell-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/west-china-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/west-china-second-university-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/west-german-study-group/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/women-s-hospital-school-of-medicine-zhejiang-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/xi-an-xintong-pharmaceutical-research-co/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/xijing-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/xuexin-he/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/yale-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/yantai-yuhuangding-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/yong-fang/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/yong-zhang-md/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/yonggao-mou/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/yonsei-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/yuhan-corporation/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/zhangzhou-municipal-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/zhejiang-cancer-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/zhejiang-provincial-people-s-hospital/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/zhejiang-university/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/zhijie-wang/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/zin-w-myint/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/zsky-biotech/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01078441/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02811354/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06658405/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03245905/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00924066/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06737731/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00054145/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00200395/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02727777/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02878057/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05805501/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02650401/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03321981/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02150967/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06389500/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00064207/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01785992/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03241745/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05554939/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07083375/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02040857/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05994001/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00003619/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05417230/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04763928/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04410367/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04093167/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02951767/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06082167/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03467867/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01091207/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07547592/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06784336/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00281736/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05912205/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06445166/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03602066/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04071756/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04975451/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05934331/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04824937/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04532372/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03038672/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05280457/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03256981/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04299581/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07099430/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01090830/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00612430/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06325683/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07198841/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01820754/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00063154/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02208037/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07239245/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00857545/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00079872/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06236139/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04245839/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01543412/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02228681/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03410030/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02004028/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05609370/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06101394/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06586866/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05323656/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07590531/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02771353/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03028337/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05041257/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04565665/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06535607/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05908786/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06078969/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01005641/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02311205/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00028795/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00088595/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02133677/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06713057/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01991457/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01402401/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05631912/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00625573/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00004254/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02067156/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01147822/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05188729/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02544737/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03536039/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03879577/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02225275/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03300557/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03224767/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03077841/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01918241/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03713294/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05024994/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03712956/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04158856/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00756951/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07455331/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07382531/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00003195/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02433639/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01714739/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02978612/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05784012/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02597712/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00027781/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00520481/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05833919/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00003928/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00666783/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00612183/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00688883/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00389441/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03071094/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00591851/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07229339/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04565275/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05190575/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01120275/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02705612/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03835819/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02046928/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01739894/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00466531/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06331845/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00506857/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02364557/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01796028/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06773936/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06218771/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04586244/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01910844/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02571829/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04720131/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04535102/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03898102/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05481645/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01072045/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05853172/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05148195/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00002639/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00193128/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02748707/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04924192/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00303836/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03879811/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00781911/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05841771/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02606305/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03481556/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03850522/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02383251/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03448731/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06132737/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03597295/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06820957/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06208657/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02827201/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07441512/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01585428/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01888965/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03053167/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00126607/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01412307/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04929392/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02890511/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02291211/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07432022/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01576029/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00406302/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04398953/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02569801/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01280201/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04321330/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00254267/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06182800/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00014092/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04218071/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02411344/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06777264/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00406809/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06141109/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03520257/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04924101/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03943901/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02542930/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02846428/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00321828/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03392428/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01164228/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05181865/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07153965/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01855607/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05483400/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00202800/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03726736/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01082211/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06582771/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00736944/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00372944/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00033644/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05182944/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02414945/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00354172/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04406272/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05478239/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06252675/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03041701/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01187212/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02037230/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00038428/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01415765/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00529100/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04118036/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05312671/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00983944/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00830544/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03655444/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00197444/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00077064/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05669664/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00610857/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05490719/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05719428/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00087165/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06237400/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00856492/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03919071/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01225744/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00506844/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02789657/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07314619/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06654830/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03465592/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04224636/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04554836/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06831136/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04172571/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00461344/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00283244/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04866134/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03169764/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04363164/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06390839/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01891357/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07334301/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02314481/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05588219/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00165230/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02464228/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00121628/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01745367/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00114192/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00076011/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03557411/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03499834/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06758557/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02685657/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03668119/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05720130/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00327600/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03232307/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03007407/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01258192/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05490771/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00171834/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05908916/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02953652/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01053949/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00003758/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01545648/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05052255/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01882868/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00313768/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03328078/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00026143/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07156643/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00485485/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00508443/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02432417/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00976768/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02057640/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05295589/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01259089/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07025889/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01268150/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05648006/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05710406/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02401347/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06356155/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00003008/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04617925/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03444025/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00471276/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06126276/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04245514/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06646016/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03346304/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07274384/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02676349/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06067438/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06780085/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02400476/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01012817/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05035914/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02960906/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05398484/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01175733/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00493649/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00450255/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04584255/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00321815/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00005976/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01829217/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01737450/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02812706/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06344052/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04569747/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02052778/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05506943/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02481635/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00742625/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04462276/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02651506/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04995016/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07296484/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04689347/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01524926/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00066378/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04863885/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06547476/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03513952/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00004085/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04383743/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03993678/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07512076/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04191616/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02138214/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04084158/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04547855/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07645326/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03736889/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00303108/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06784648/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05419817/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01116648/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07388758/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04657068/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05162118/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06975410/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00055913/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05103358/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01684215/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02981108/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01318447/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05798455/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06885385/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04599140/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00841191/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05640791/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04492033/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02205333/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03195478/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03166176/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01285817/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06288191/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03285321/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04669587/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01025453/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05988372/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05722977/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01905657/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04345900/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03587311/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06330064/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07502287/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07258121/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00245063/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00332163/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02019693/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01102231/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05952453/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00570401/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01101412/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03190967/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00365144/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05983367/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02314364/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04570839/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06517212/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06329830/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04962867/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06282536/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04693234/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04310709/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05312398/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05315687/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03165721/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02669914/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00971932/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04396821/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00828854/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02558894/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02924883/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06911827/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00787761/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07673341/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05824494/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00601627/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02159066/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00604461/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05359861/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05220722/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00162669/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02135822/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05651594/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03698994/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00550173/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03625141/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03442556/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05799820/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00019890/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03402880/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00977379/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04765462/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01262027/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01055197/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04197297/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05210413/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01581060/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01046461/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02642042/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03230318/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04045613/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02648724/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01378962/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06041724/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00309179/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06387342/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07205718/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01487720/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02159820/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05120596/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05357196/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07111546/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03704688/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07259590/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07458113/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01861496/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02431559/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01631279/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00002504/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00730158/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05113355/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01823835/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00495625/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00478140/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01525589/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00918385/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03284385/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05200143/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03664115/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07410676/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06364917/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07287917/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03420508/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01858389/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05551117/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01267240/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00503984/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03468985/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07145255/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02314143/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03427814/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03639714/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01101906/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03752333/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05991349/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04504916/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04841538/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00024258/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02322814/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00874614/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03307616/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00019604/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06924606/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02301143/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03149549/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01399684/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07228247/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03191149/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00609804/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01625286/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01004003/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00345761/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00422903/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05859373/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04116541/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05399654/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02866383/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04072042/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01803503/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01896856/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00474383/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05431270/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00622466/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01557959/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02844582/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03505320/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02084732/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03516487/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01430585/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04701307/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04506567/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05949632/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06031584/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00136955/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02307500/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07249892/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03750916/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00506155/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01084655/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04039867/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00182767/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01112293/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02938793/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05806671/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04408599/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06390852/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07610798/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02033993/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01898117/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04668508/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03278106/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06981325/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00351858/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04632433/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00631852/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00513435/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01849250/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02806648/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03346135/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05746208/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03645876/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03083691/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07617818/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01776008/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00573989/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00118352/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01915472/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03065764/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06478264/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07172412/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07314528/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03963193/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03065621/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05143099/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04402073/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02339922/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00049127/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03470805/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00087269/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01427205/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02296242/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05145569/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03563729/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02639910/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00513461/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04575961/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01609790/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03534180/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00666588/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03483103/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03466320/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03206203/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00841204/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02757326/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00540176/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00305838/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03130348/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01110785/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03823625/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00466752/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02656615/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04754815/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02210858/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01867606/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07570849/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07416058/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01215578/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01222715/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05320406/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07505849/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06991738/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07551349/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01442649/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04577755/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01414855/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01529827/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05149170/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00383266/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00051051/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00792142/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00958854/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04109742/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05184803/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02243579/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00098813/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01591421/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00303849/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06128863/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00023998/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01136967/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00609336/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01902173/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02520141/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01805037/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02392377/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04318223/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03146962/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04775862/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00057941/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03792724/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04417062/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03513562/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07323056/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00114283/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00304083/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06152523/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01979523/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07580079/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04493203/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07550205/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02759588/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00595088/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07248020/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00089154/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02521090/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02480010/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06640283/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01215032/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01111058/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01854255/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00040755/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04154826/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00770185/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02743364/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00081263/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00450749/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07059338/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05599048/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02988843/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00079131/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00618345/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01729845/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00087139/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06532539/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02734537/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01661972/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00416715/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03601806/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05580861/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02986451/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05467670/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06869473/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07243951/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07662031/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01469429/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04661137/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04476329/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03851445/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06128070/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05377905/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03944772/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00754494/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00027872/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03548428/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02427841/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01608022/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04190056/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00075881/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02028988/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01585194/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00809796/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01988831/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07054242/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00560794/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00408603/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00005942/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03306472/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02536794/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03340129/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02158975/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00556205/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00162266/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06761027/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07071103/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05468138/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04919642/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02085070/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01190462/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00611962/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01620970/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00710762/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04762888/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05538897/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01911273/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00087373/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05327686/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05135715/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00313235/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01530698/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03359954/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01348256/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00085397/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06718933/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07367516/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05190705/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06484361/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07106892/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07275216/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05800366/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03504488/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07466303/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02588651/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07405151/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00019929/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06001255/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07217184/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07281209/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05216965/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03007030/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04152499/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04126200/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07408063/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06788964/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00814892/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07186842/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07489703/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07572123/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01926639/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06649331/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03452228/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07439094/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06303505/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01146262/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06823427/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06545617/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00637117/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06989671/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06439771/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07657130/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03248492/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03668730/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07150091/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07227597/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07093970/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07488676/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02388490/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06839066/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06224673/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07643103/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04538742/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04820179/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05631262/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04745949/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06848699/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07198633/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04561206/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03602079/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03384940/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06145308/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07193160/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06048718/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07460375/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03409432/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07459998/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04659044/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05144009/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06775236/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06655818/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03500380/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01472146/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06941272/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06157892/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04082936/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04479436/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07677475/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07514975/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00266110/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06311214/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05633615/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00088985/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07329322/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07343453/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06843447/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02744612/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07612787/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07102004/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07630974/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03233347/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06587425/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01973322/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03933670/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06377566/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04681131/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06686394/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03610360/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03386513/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04132960/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06105008/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06957561/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04795869/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01901653/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05141786/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06792435/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05280470/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07501169/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05914116/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05613088/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06525298/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00334776/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07192120/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06798207/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07087860/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07592767/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06793332/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01846871/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03656042/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04998669/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04802759/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00198380/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06509997/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06818643/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05887609/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05134519/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07139977/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05980481/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03712202/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03856359/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06483334/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06533826/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07618923/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07269782/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05652855/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07111520/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06822543/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05749588/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07251062/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07253142/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06966453/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05714839/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02033616/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03014804/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07150208/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03400917/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07514533/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07667335/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01734564/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01896999/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07401537/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07589049/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01534078/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01197625/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00345293/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01431196/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06328387/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07152782/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02310971/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01771107/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05535244/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06962865/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02688712/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06892548/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02674568/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07529808/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07077564/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06000033/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02792582/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05205850/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07259226/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05824325/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01237678/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06956690/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06210490/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07181161/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07394218/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06734182/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03729596/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05039073/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07474727/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02978547/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07459738/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07317778/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06907615/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05297552/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05673785/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07692334/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06067269/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00499083/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01492088/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06395103/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05011188/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07365280/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07150104/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06100705/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06219941/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06492005/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04487756/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07416253/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06173037/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05775471/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05912816/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06742892/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02230306/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07307287/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05308225/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02677155/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07070232/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00902577/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07459751/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06551051/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06657222/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04032704/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05064358/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07630103/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04606914/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04587687/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01006044/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03425279/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07518979/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07366840/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06038396/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05453396/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00442754/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00436930/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07201675/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07579598/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05996952/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02880943/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01631552/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05141747/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06959108/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06710132/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05578287/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01648348/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05575804/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03113500/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04838964/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01111461/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05798156/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02504229/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05594095/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06178601/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01393717/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06842498/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07368543/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04839510/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01153113/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06305767/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07220616/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06362252/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03684694/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05460273/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05600686/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05041972/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07340398/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07428044/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04887870/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02988817/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01780662/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06003231/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00776295/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01068353/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04523688/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06797999/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06637423/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04995419/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04242459/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02405338/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07243418/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02828124/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07419880/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04032626/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06496490/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07453394/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07509515/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07279597/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07472647/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01856933/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00929019/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07487519/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07193511/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06265727/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06676917/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01782742/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07649980/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00197860/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07130383/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06007729/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06857279/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04300556/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04073602/ 2026-07-11T05:13:58.109Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07061639/ 2026-07-11T05:13:58.109Z monthly 0.5